Literature DB >> 24357871

Exposure to maternal medications: a case of lockjaw.

Brandi Newby1, Rebecca Sherlock2.   

Abstract

Year:  2013        PMID： 24357871      PMCID： PMC3867566          DOI： 10.4212/cjhp.v66i6.1304

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN： 0008-4123


× No keyword cloud information.
  4 in total

1.  Risk for antipsychotic-induced extrapyramidal symptoms: influence of family history and genetic susceptibility.

Authors:  Meike Kasten; Norbert Brüggemann; Inke R König; Katja Doerry; Susanne Steinlechner; Liv Wenzel; Katja Lohmann; Christine Klein; Rebekka Lencer
Journal:  Psychopharmacology (Berl)       Date:  2010-11-12       Impact factor: 4.530

2.  Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.

Authors:  Henry A Nasrallah; Martin Brecher; Björn Paulsson
Journal:  Bipolar Disord       Date:  2006-10       Impact factor: 6.744

Review 3.  Extrapyramidal symptoms associated with antidepressants--a review of the literature and an analysis of spontaneous reports.

Authors:  Subramoniam Madhusoodanan; Lada Alexeenko; Renata Sanders; Ronald Brenner
Journal:  Ann Clin Psychiatry       Date:  2010-08       Impact factor: 1.567

4.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.